International cohort study indicates no association between alpha-1 blockers and susceptibility to covid-19 in benign prostatic hyperplasia patients

HIGHLIGHTS

• who: September and colleagues from the LMU Munich, Germany Lanzhou University, China have published the research: International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients, in the Journal: (JOURNAL) of 31/01/2020
• what: The authors aimed to provide this much needed evidence by studying the association between the use of alpha-1 blockers and the susceptibility to COVID-19 disease (diagnosis), related hospitalization, and requirement of intensive services. The authors provide the full details of the cohort and outcome definitions in the supplement . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.